TickerStat.comL'oreal annual stock-based compensation
2019
2020
2021
2022
2023
2024
2025
L'oreal Stock-Based Compensation Growth & History (OR)
L'oreal's stock-based compensation was €248.3M for fiscal 2025.
View full L'oreal company overviewL'oreal annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €248.3M | €9.2M | +3.85% |
| 2024 | 2024-12-31 | €239.1M | €70.6M | +41.90% |
| 2023 | 2023-12-31 | €168.5M | −€500,000 | −0.30% |
| 2022 | 2022-12-31 | €169.0M | €13.8M | +8.89% |
| 2021 | 2021-12-31 | €155.2M | €25.5M | +19.66% |
| 2020 | 2020-12-31 | €129.7M | −€14.7M | −10.18% |
| 2019 | 2019-12-31 | €144.4M | — | — |
L'oreal stock-based compensation trends
Over the last five fiscal years, L'oreal's stock-based compensation increased from €129.7M to €248.3M, a change of €118.6M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
reported stock-based compensation
TickerStat standardizes share-based compensation reported in company official filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review L'oreal source filings ↗Community posts
L’Oréal faces Arizona lawsuit over hair-relaxer safety claims
Arizona sued L’Oréal ($OR-EURONEXT), alleging that the company concealed cancer risks associated with chemical hair relaxers. The state is seeking remedies including damages, penalties and stronger warnings. The allegations concern products ...